WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (CRL) today announced that four new directors will join its Board of Directors and that four long-time members of ...
The FDA announced that it will gradually remove animal testing from the drug development process in a period of 3-5 years. This decision will negatively affect Charles River's revenues. The DCF model ...
WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL), ahead of the American Association for Cancer Research® (AACR) Annual Meeting in Chicago, IL, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results